News | Congenital Heart | April 12, 2018

Infant Heart Defects May Predict Late-Life Heart Problems in Birth Mother

Women who give birth to infants with congenital heart defects may be at increased risk of heart problems including heart attack and heart failure later in life

Infant Heart Defects May Predict Late-Life Heart Problems in Birth Mother

April 12, 2018 — Women who give birth to infants with congenital heart defects may have an increased risk of cardiovascular hospitalizations later in life, according to new research in the American Heart Association’s journal Circulation.

The study of more than one million women is the first to show congenital heart defects in newborns may be a marker for an increased risk of their mothers developing heart problems, including heart attack and heart failure, years after pregnancy.

Researchers analyzed data on women who delivered infants between 1989 and 2013 in Quebec, Canada, who had critical, noncritical or no heart defects. They tracked the women up to 25 years after pregnancy for hospitalizations related to cardiovascular disease including heart attack, heart failure, atherosclerotic disorders and heart transplants.

Compared to mothers of infants without congenital heart defects, researchers found:

  • Forty-three percent higher risk of any cardiovascular hospitalization in women whose offspring had critical heart defects; and
  • Twenty-four percent higher risk of any cardiovascular hospitalization in women whose infants had noncritical defects.

How heart defects in infants relate to post-pregnancy cardiovascular disease in their mothers is unclear, the study notes, and a genetic component cannot be excluded. In addition, because 85 percent of infants with heart defects now survive past adolescence, the psychosocial impact of congenital heart disease on caregivers may have a cumulative effect over the long term.

“Caring for infants with critical heart defects is associated with psychosocial and financial stress, which may increase the mothers’ long-term risk for cardiovascular disease,” said Nathalie Auger, M.D., the study’s lead author and an epidemiologist at the University of Montreal Hospital Research Centre in Montreal, Quebec, Canada.

Researchers believe the study provides an opportunity for these mothers to benefit from early prevention strategies and counseling to reduce their risk of cardiovascular disease – the leading cause of death in women.

Healthcare providers, like obstetricians, who treat and follow mothers in the early stages of dealing with children who have heart defects can help women understand and minimize their risk, Auger said.

“Those physicians are very well-positioned to inform women about this possibility, the greater risk of heart disease, and to provide recommendations for targeting other risk factors like smoking, obesity and physical activity,” she said.

Some limitations of the research include the fact that women were young at the start of study, so for many, the 25-year follow-up did not extend past menopause, which excluded the highest risk period for cardiovascular disease. And, because researchers used existing medical data, they did not have detailed risk factor information on the women, such as body weight and smoking status. These are important points that should be considered in future studies, researchers noted.

Co-authors are Brian Potter, M.D., C.M., S.M.; Marianne Bilodeau-Bertrand, M.Sc.; and Gilles Paradis, M.D., M.Sc. The authors reported no conflicts of interest. The Heart and Stroke Foundation of Canada and the Fonds de recherche du Québec-Santé funded the study.

For more information: www.circ.ahajournals.org

 

Related Content

New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
AHA Statement Warns Hookah Smoking May Harm the Heart
News | Cardiac Diagnostics | March 08, 2019
Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels...
PTSD Alone Does Not Increase Heart Disease Risk in Veterans
News | Cardiac Diagnostics | February 20, 2019
February 20, 2019 — Post-traumatic stress disorder (PTSD) by itself does not explain the...
Hormone Therapy May Increase Cardiovascular Risk During Gender Transition
News | Cardiac Diagnostics | February 18, 2019
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular...
IBM and Broad Institute Launch AI Initiative for Cardiovascular Disease Risk Prediction
News | Cardiac Diagnostics | February 15, 2019
IBM Watson Health and the Broad Institute of MIT and Harvard are launching a research partnership aimed at developing...
Nearly Half of All U.S. Adults Have Cardiovascular Disease
News | Cardiac Diagnostics | January 31, 2019
January 31, 2019 — Nearly half (48 percent, 121.5 million in 2016) of all adults in the United States have some type
Frequent Red Meat Consumption Triples Levels of Chemical Associated With Heart Disease
News | Cardiac Diagnostics | January 23, 2019
Researchers have identified another reason to limit red meat consumption: high levels of a gut-generated chemical...
Overlay Init